Contents

Current Neuropharmacology, Volume 3 - Number 1

Editorial [HotTopic: New and Emerging Approaches to Treatment of Schizophrenia (Guest Editors: Gene G. Kinney and P. Jeffrey Conn)]

, 3(1): 1 - 2

Gene G. Kinney and P. Jeffrey Conn


DOI: 10.2174/1570159052773431




Partial Dopamine Agonists and the Treatment of Psychosis

, 3(1): 3 - 8

Carol A. Tamminga


DOI: 10.2174/1570159052773404




Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

, 3(1): 9 - 34

Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn


DOI: 10.2174/1570159052773369




Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia

, 3(1): 35 - 43

Gene G. Kinney and Cyrille Sur


DOI: 10.2174/1570159052773387




GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

, 3(1): 45 - 62

David W. Volk and David A. Lewis


DOI: 10.2174/1570159052773396




Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders

, 3(1): 63 - 71

Cyrille Sur and Gene G. Kinney


DOI: 10.2174/1570159052773413




Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs

, 3(1): 73 - 85

W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig and J. Marksteiner


DOI: 10.2174/1570159052773440




Author Index to Volume 2

, 3(1): 87

Bentham Science Publishers


DOI: 10.2174/1570159052773422




Subject Index to Volume 2

, 3(1): 89 - 93

Bentham Science Publishers


DOI: 10.2174/1570159052773378




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science